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Abstract: Obstructive sleep apnea (OSA) is often associated with hypertension and other cardio-
vascular diseases. Blood pressure (BP) variability is part of the assessment of cardiovascular risk. 
In OSA, BP variability has been studied mainly as very short-term (beat-by-beat) and short-term 
(24-hour BP profile) variability. BP measured on consecutive heartbeats has been demonstrated 
to be highly variable, due to repeated peaks during sleep, so that an accurate assessment of 
nocturnal BP levels in OSA may require peculiar methodologies. In 24-hour recordings, BP 
frequently features a “nondipping” profile, ie, <10% fall from day to night, which may increase 
cardiovascular risk and occurrence of major cardiovascular events in the nocturnal hours. Also, 
BP tends to show a large “morning BP surge”, a still controversial negative prognostic sign. 
Increased very short-term BP variability, high morning BP, and nondipping BP profile appear 
related to the severity of OSA. Treatment of OSA slightly reduces mean 24-hour BP levels and 
nocturnal beat-by-beat BP variability by abolishing nocturnal BP peaks. In some patients OSA 
treatment turns a nondipping into a dipping BP profile. Treatment of arterial hypertension in 
OSA usually requires both antihypertensive pharmacological therapy and treatment of apnea. 
Addressing BP variability could help improve the management of OSA and reduce cardiovascular 
risk. Possibly, drug administration at an appropriate time would ensure a dipping-BP profile.
Keywords: sleep apnea, ambulatory blood-pressure monitoring, beat-by-beat measurements, 
blood-pressure dipping, morning blood-pressure surge
Introduction
Obstructive sleep apnea (OSA) is a well-known cardiovascular risk factor. In patients 
with OSA, cardiovascular diseases have increased incidence and are associated with 
worse functional outcomes and increased mortality.1 Systemic hypertension, which 
is often found in OSA, can importantly affect cardiovascular health. Also, altered 
blood pressure (BP) variability may carry some additional risk for higher incidence 
and faster progression of cardiovascular disease.2,3 Both the degree and pattern of BP 
variability have prognostic implications. Many methods and calculations have been 
proposed for assessment of BP variability, but physiological and clinical meanings of 
each of them are not always clear.4,5 In this article, after a brief review of assessment 
and implications of BP variability in the general population, we focus on BP variability 
in adult OSA, taking into account methodological, clinical, and therapeutic aspects.
Types of BP variability
BP variability can be defined as BP fluctuations occurring over time. It can be studied 
in the very short term (beat to beat), short term (24 hours), midterm (day to day), or 
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long term (visit to visit).2 Whatever the time scale, sympa-
thetic activity is a determinant of BP variability in response 
to a variety of external and internal stimuli. In the very short 
term, respiratory influences, postural changes, emotional 
factors, or environmental conditions are a source of BP 
changes, while arterial and cardiopulmonary reflexes, arterial 
compliance, blood viscosity, and humoral factors modulate 
their amplitude.2 Twenty-four-hour BP changes are affected 
by endocrine influences, genetic factors, degree of diurnal 
physical and mental activity, and more than anything else by 
the wake–sleep cycle.6,7 In normal subjects, BP decreases 
when falling asleep, reaches its lowest values and highest 
stability during slow-wave sleep (SWS), and shows the 
highest variability during rapid eye movement (REM) sleep.8 
Midterm and long-term BP variability are representative of 
BP burden and reflect the degree of control of BP over longer 
periods. Similarly to very short- and short-term variability, 
their increase is considered an unfavorable prognostic sign.2
Measurement techniques should be appropriately chosen 
to study each kind of BP variability. Very short-term vari-
ability can be studied invasively by means of measurements 
performed with intra-arterial catheters, or noninvasively by 
means of a photoplethysmographic sensor applied at a finger 
using the volume-clamp methodology.9,10 In addition, a new 
noninvasive method to measure beat-to-beat BP at the wrist 
by applanation tonometry has been recently described.11 
Twenty-four-hour changes can be detected by BP measure-
ments taken at different times of the day, eg, morning and 
evening, preferably with home measurements taken by 
patients themselves (home BP monitoring [HBPM]), or by 
instruments that automatically measure BP at fixed intervals 
during the 24 hours (ambulatory BPM [ABPM]). However, 
HBPM may provide information only on waking BP, whereas 
BP measurements during sleep can be obtained only with 
ABPM. For assessment of midterm BP variability, HBPM 
may be a better choice than ABPM, as ABPM may not be 
easily tolerated on consecutive days. Patients should prefer-
ably use validated automatic devices and receive appropri-
ate training and instructions about the correct modalities to 
perform the measurements.12 Similarly to midterm variability, 
long-term BP variability may be best monitored by HBPM. 
Whatever the type of BP assessment to perform, office BP 
measurements are far from ideal, mainly due to the common 
“white-coat effect”, which can lead to an overestimation 
of patients’ usual BP levels.2 Evaluation of mid- and long-
term variabilities is particularly useful in the management 
of hypertensive patients, but very little is known about their 
behavior in OSA. Therefore, we focus our attention on very 
short- and short-term variability.
Beat-to-beat BP measurements: very 
short-term BP variability
Beat-to-beat BP measurements are ideal to monitor fast 
changes in autonomic modulation, eg, in awake subjects 
performing the Valsalva maneuver, which is part of the 
assessment of patients with autonomic disorders, eg, ortho-
static hypotension.13 Among the most common applications 
of beat-to-beat BP recordings is the measurement of cardiac 
baroreflex sensitivity, which can be assessed both during 
wakefulness and during sleep. Its evaluation may be useful 
for prognostic purposes and to assess therapy effectiveness 
in several diseases, although present knowledge has not yet 
allowed us to adopt it in clinical routine.14 During sleep, beat-
to-beat measurements reveal sudden BP rises when events 
disturbing sleep occur, especially when associated with elec-
troencephalography changes (cortical arousals).15 BP surges 
can be a cause of increased nocturnal BP variability, as is 
usually observed in OSA. In this condition, beat-to-beat BPM 
may reveal important aspects of BP behavior that would be 
undetected by any other BP assessment method.
Twenty-four-hour BP: short-term BP 
variability
Many types of analyses may be done on 24-hour BP values, 
including separate measurements of waking and sleeping BP 
and the 24-hour BP profile. Today, it is commonly agreed that 
mean BP levels have a higher influence on cardiovascular 
risk than the 24-hour BP profile.2,16,17 In particular, nocturnal 
BP levels are the most useful predictors of cardiovascular 
disease.16,18–20 Thresholds for normal BP values, assessed 
by ABPM, have changed over time. Until recently, diurnal 
values ≥135/85 mmHg and nocturnal values ≥120/70 mmHg 
have been considered representative of diurnal and noctur-
nal hypertensive BP levels.21 According to new guidelines, 
diurnal values ≥130/80 and nocturnal values ≥110/65 mmHg 
should be considered hypertensive.12
However, some types of circadian BP changes also carry 
an independent risk, and the evaluation of the circadian 
BP profile helps to understand mechanisms governing BP 
changes better and establish more appropriate therapy in 
each hypertensive subject. In normal subjects, BP usually 
exhibits one peak early in the morning and one peak late in 
the afternoon or early evening.6,7 Either higher morning or 
evening BP have been reported, as some studies, mainly in 
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Asian subjects, found higher values in the morning, while 
other studies, mainly in European subjects, in the evening.22 
It has been claimed that morning BP better predicts car-
diovascular risk than evening BP,23 particularly when the 
morning:evening BP ratio increases.24
The 24-hour BP profile is evaluated mainly as change in 
mean BP from day to night. Since sleep is a major determi-
nant of the diurnal change, usually causing a decrease in BP, 
BP measurements taken during waking and sleeping should 
be considered separately. For the sake of simplicity, fixed 
time ranges relevant to estimated waking and sleeping time 
are often used. They can be set as wide-fixed or narrow-fixed 
intervals. With the first method, all 24-hour measurements are 
taken into account and subdivided into waking and sleeping 
values. According to the other method, periods estimated as 
transition times between waking and sleeping are discarded.25 
Ideally, waking and sleeping measurements should be esti-
mated individually based on sleep diaries or (better) on results 
of monitoring by instruments helping to define waking and 
sleeping times, like actigraphs.26
Although definitions may vary,19 the following BP 
24-hour profiles are commonly considered: “dipping”, mean 
nocturnal reduction in BP by 10%–20%; “nondipping”, noc-
turnal reduction in BP between 0 and 10%; “reverse dipping” 
or “riser” pattern, increase in mean BP during the night; 
“extreme dipping”, nocturnal reduction in BP >20%. While 
the dipping pattern is considered physiological and associ-
ated with the lowest risk, nondipping and extreme-dipping 
patterns carry an intermediate risk and the reverse-dipping 
profile carries the highest risk of cardiovascular events.27
Another way to look at the 24-hour BP variability is to 
compare nocturnal and morning BP to measure the “morning 
BP surge” (MBPS). BP normally increases after morning 
awakening.6 An increase in cardiac output in young subjects 
and increased arterial stiffness in the elderly play a role in 
determining MBPS.28 Elderly subjects usually have higher 
MBPS compared to young subjects. The definition of a nor-
mal MBPS rise is lacking, but a J- or U-shaped relationship 
between the degree of MBPS and cardiovascular risk has 
been proposed.28
MBPS can be calculated following different criteria 
 (Figure 1). The most commonly used are: sleep-trough morn-
ing surge, defined as the difference between the average BP 
over 2 hours after waking and the average of three consecutive 
BP recordings, centered on the lowest reading during sleep; 
and the prewaking morning surge, defined as the difference 
between the average BP recordings 2 hours after waking and 
average BP recordings over 2 hours before waking up.28,29 The 
MBPS has been proposed as a potential contributor to the 
increased incidence of cardiovascular events in the morning 
hours. However, while some authors have confirmed the 
importance of the MBPS as a cardiovascular risk factor,29–31 
others have reported opposite findings, with less risk in 
subjects with elevated MBPS.32–34
An apparently obvious objection raised to the MBPS con-
cept is that subjects with high MBPS may actually show low 
Figure 1 Measurements of morning blood pressure surge (MBPS).
Notes: Sleep-trough MBPS definition: mean blood pressure in the 2 hours following morning awakening – lowest nocturnal blood pressure (measured as the mean of three 
measurements centered on the lowest nocturnal value). Prewaking MBPS definition: mean blood pressure in the 2 hours following morning awakening – mean blood pressure 
in the 2 hours preceding morning awakening. Copyright ©2003. American Heart Association, Inc. Reproduced from Kario K, Pickering TG, Umeda Y, et al. Morning surge in 
blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107(10):1401–1406 (https://www.
ahajournals.org/doi/10.1161/01.cir.0000056521.67546.aa).29
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nocturnal BP levels, which is difficult to reconcile with the 
well-known risk represented by nocturnal hypertension. Along 
the same lines, a high MBPS may be the effect of extreme 
dipping, such that it could be associated with increased car-
diovascular risk due to very low nocturnal BP and not to high 
morning BP. Although an elevated MBPS is more common 
among extreme dippers, only a fraction of them have a high 
MBPS. According to one study, only 24% of extreme dippers 
have a high MBPS. Also, when extreme dipping and high 
MBPS coexist, increased cardiovascular risk appears to be 
associated more with the morning BP rise than with exces-
sively low nocturnal BP.29 Finally, a high MBPS, assessed by 
sleep-trough morning surge, may be associated with nocturnal 
hypertension in subjects who show a progressive increase in 
BP from the beginning to the end of the night (Figure 2).35
In clinical practice, ABPM is typically used in specialized 
hypertension clinics, especially for patients who have resis-
tant or refractory hypertension. However, the importance and 
usefulness of ABPM measurements should lead to it being 
used clinically more often than it is at present.
BP variability in OSA
Patients with OSA are characterized by a high prevalence of 
arterial hypertension, which may exceed 50%,36 and by high 
BP variability. In fact, OSA is frequently associated with 
factors, often interrelated, with important influences on the 
cardiocirculatory system, like oxidative stress, inflammation, 
endothelial dysfunction, and high sympathetic tone,1 which 
increase during sleep as an immediate effect of respiratory 
disorders and remain high during wakefulness.37 These fac-
tors may increase BP levels and variability chronically.
The greatest peculiarities in BP behavior in OSA are 
seen during sleep. Pulsus paradoxus, ie, inspiratory reduc-
tion in BP ≥10 mmHg, occurs in obstructed breaths with 
strong respiratory efforts.38,39 More importantly, obstructive 
apnea termination is characterized by a BP peak lasting 
only a few seconds that is followed by a return of BP to 
or below baseline.40 Therefore, the higher the number of 
apneas during sleep, the higher the number of BP oscilla-
tions. However, the amplitude of BP peaks is highly variable 
in relationship to sympathetic reactivity, which in turn is 
related to end-apneic hypoxemia, occurrence and strength 
of arousals at the end of each event, age of patients, and 
normotensive/hypertensive state.41–43 The rate and amplitude 
of BP peaks during sleep are fundamental determinants of 
the degree of variability of BP during the night and of the 
mean change in BP from day to night. Apneic events are 
less frequent in SWS,44 and are usually longer and associ-
ated with worse hypoxemia in REM sleep.45 Therefore, the 
respective duration of the various sleep stages may also 
influence nocturnal BP behavior in OSA through rate and 
severity of events in each of them. Due to the numerous, 
large, and rapid changes in BP during the night, information 
on BP in OSA is heavily affected by the method used for 
its assessment. Optimal detection of different parameters 
describing BP levels or variability may take advantage of 
different monitoring techniques.
Role of frequent diurnal and nocturnal BP 
measurements: very short-term variability
Continuous BP monitoring is not easily tolerated for pro-
longed periods of time, and may give rise to frequent  artifacts, 
Figure 2 Different blood-pressure profiles in two subjects with high sleep-trough morning blood pressure surge (MBPS).
Notes: High MBPS may or may not be associated with low nocturnal blood pressure. Copyright ©2005. American Journal of Hypertension, Ltd. Reproduced from Kario K. 
Time for focus on morning hypertension: pitfall of current antihypertensive medication. Am J Hypertens. 2005;18(2 Pt 1):149–151, by permission of Oxford University Press.35
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eg, due to limb movements. Therefore, beat-by-beat BP 
measurements are often performed during short representa-
tive time lapses. When recorded during wakefulness, their 
analysis is not more useful in OSA than in normal subjects, 
whereas they provide valuable and unique information on 
BP behavior in sleeping OSA subjects.
Intra-arterial measurements were already obtained in 
very early studies in OSA patients, and revealed the rapid 
oscillations associated with apneic events40 that were later 
confirmed with the use of noninvasive techniques.41,43,46–50 
Beat-by-beat evaluation of BP showed that during sleep, 
compared to the immediately preceding quiet wakefulness, 
mean BP falls if breathing is unobstructed, while it changes 
little during nonapneic snoring.47 Conversely, in OSA, mean 
BP during sleep can be higher than during quiet wakefulness, 
with a trend to highest values during REM sleep.46,51
The advantage of beat-by-beat BP measurements in 
OSA is that they provide accurate information about very 
short-term variability in BP, although they are less accurate 
in the assessment of absolute BP values. During wakeful-
ness, beat-by-beat measurements show increased variance 
in BP proportional to the severity of OSA.52 Progression 
from quiet waking to non-REM to REM sleep is associated 
with an increasing coefficient of variation in BP values.46 
The SD of BP values during sleep is higher in OSA than in 
non-OSA subjects, although in both groups BP variability 
is similarly modulated by sleep stage, being lowest during 
SWS. Frequency of arousals and respiratory events are cor-
related with systolic and diastolic BP SD, although they do 
not fully explain them.49
We used beat-by-beat BP measurements to compare accu-
racy of different sampling rates in the assessment of mean 
nocturnal BP in subjects with severe OSA and in non-OSA 
controls. In each subject, mean systolic and diastolic BP were 
calculated, averaging measurements taken on all heartbeats of 
one night. Then, mean BP values of the same night were mea-
sured, averaging values of heartbeats sampled each 5, 10, 15, 
20 and 30 minutes. The mean values obtained from heartbeats 
sampled at each rate were compared to values calculated on 
all heartbeats. At all sampling intervals in both patients and 
controls, mean differences between mean systolic and diastolic 
nocturnal BP values calculated on sampled and all-night heart-
beats were small, but the scatter of the differences was higher 
in the OSA group, especially when long sampling intervals 
were used (Figure 3). In the OSA subjects, a sampling rate 
about three times that in the non-OSA subjects was necessary 
for a similarly accurate assessment of mean nocturnal BP.53
It has been claimed that cuff inflations for ABPM mea-
surements can cause arousals, transiently increasing BP, so 
that BP levels detected by ABPM are higher than during 
undisturbed sleep.54 In OSA subjects, this result proved true 
for systolic pressure, which is measured soon after brachial 
cuff inflation, but not for diastolic pressure, which is mea-
sured later so that it is less affected by the arousal.55 Our 
experience with five sleepy patients with severe OSA was 
that the time taken by ABPM to perform each measurement 
was usually longer than an apneic cycle, ie, an apnea and 
the following ventilation interval, and rarely caused arous-
als prematurely interrupting the apnea occurring during the 
measurement (Figure 4).53 Therefore, frequent BP measure-
ments by ABPM may not significantly disturb sleep and BP 
behavior in severe OSA patients.
Whatever the time between measurements obtained at 
fixed intervals, ABPM may hardly be able to reveal extreme 
BP levels, which are often (but only transiently) reached in 
Figure 3 Means ± SD of (A) ΔPs and (B) ΔPd values in control () and obstructive 
sleep apnea () subjects for each sampling interval.
Notes: ΔPs and ΔPd: differences in mmHg between the mean nocturnal blood 
pressure values, respectively systolic and diastolic, obtained from sampled 
single heart beats and from all heart beats. Copyright ©2000. ERS Journals Ltd. 
Reproduced from Marrone O, Romano S, Insalaco G, Bonsignore MR, Salvaggio A, 
Bonsignore G. Influence of sampling interval on the evaluation of nocturnal blood 
pressure in subjects with and without obstructive sleep apnoea. Eur Respir J. 
2000;16(4):653–658.53
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OSA at night. To overcome this problem, a nocturnal BPM 
method triggered by occurrence of oxygen desaturation 
has been developed.56 This method shows a fair degree of 
reproducibility,57 but the time required for a measurement 
and the short duration of the BP rise may reduce the accu-
racy of detection of BP peaks. However, it represents a clear 
advancement in the assessment of nocturnal BP in OSA with 
respect to ABPM.
Twenty-four-hour BP profile: short-term 
BP variability
Some information about the diurnal BP changes in OSA has 
been obtained with measurements taken in the evening and 
the next morning, after awakening. According to this meth-
odology, the morning BP levels in OSA tend to exceed the 
evening ones. Most studies have reported that the evening-
to-morning BP difference was correlated with OSA severity 
(Table 1).48,58–64
A large number of studies have been based on ABPM, 
with nocturnal BP measurements taken every 15, 20, or 
30 minutes. Surprisingly, the first ABPM studies did not 
 demonstrate increased nocturnal BP in OSA.65,66 Rather, one 
underscored the occurrence of large drops in BP in some 
subjects with mildly elevated apnea/hypopnea index (AHI) 
values, but large oxygen saturation falls. This observation 
remained isolated and unexplained. However, recruited 
patients were old, and increased arterial stiffness could be 
responsible for high diurnal BP values and blunted BP reac-
tivity to sleep-respiratory disorders and arousals.65 Instead, 
most of the following studies reported that patients with 
OSA showed a nondipping more commonly than a dipping 
BP pattern.67–72
In OSA, use of ABPM has also proved useful in high-
lighting high prevalence of masked hypertension, ie, normal 
office BP values with high mean values at the ABPM assess-
ment. Masked hypertension in OSA could be a consequence 
of mean nocturnal BP exceeding normal levels.73 However, 
two studies found that it could frequently also be due to high 
diurnal BP values detected only by ABPM.74,75
Other studies extended analysis of ABPM recordings 
beyond mean diurnal and nocturnal BP (Table 2).76–79 Alto-
gether, OSA, and especially severe OSA, was associated 
Figure 4 Fragment of a polygraph recording in a representative sleepy patient with severe obstructive sleep apnea.
Notes: Patient undergoing simultaneous continuous finger blood pressure monitoring and ambulatory blood pressure monitoring (ABPM). Top to bottom: pressure 
detected by an open hose placed under the cuff for ABPM measurements; beat-by-beat blood pressure (BP); nasal airflow; oxyhemoglobin saturation (SaO2). A flat airflow 
signal identifies apnea time. In this patient, apnea duration was similar before and during ABPM measurement, which indicates that the cuff inflation did not cause any arousal 
shortening habitual apnea duration. ABPM measurement required a time exceeding the duration of an apnea cycle, ie, of an apnea and following ventilation. During that period, 
BP values largely varied, but only one systolic and one diastolic value were obtained by ABPM.
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not only with increased nocturnal but also with increased 
morning BP. Differences in diurnal and evening BP observed 
between subjects with and without OSA were milder, con-
firming the results obtained with waking evening and morn-
ing measurements described earlier.
Factors associated with high BP levels and nondipping 
profile observed at ABPM have been investigated in several 
cross-sectional studies. Significant relationships between 
increased AHI or oxygen desaturation index (number of 
oxygen saturation dips per hour of sleep) and reduced noc-
turnal BP dipping have been found in community and OSA 
populations.59,68,69,80 Other studies on OSA, while  confirming 
a role of nocturnal hypoxemia, stressed the importance 
of arousals as possible determinants of nocturnal BP and 
24-hour BP profile.76,81 By contrast, another study could 
not demonstrate differences between dippers and nondip-
pers in the rate of arousals or SWS duration.71 Differences 
between studies could be at least partially accounted for 
by variable relationships of the nondipping phenomenon 
in different subjects. In fact, according to some authors, in 
young OSA patients nondipping was correlated with the 
severity of respiratory disorders, and in elderly patients with 
reduced SWS and REM and increased stage 1 duration.82 
In a subsequent study, the same authors demonstrated that 
Table 1 Studies based on morning and evening BP measurements
Authors Subjects under study Findings
Hoffstein and 
Mateika58
611 suspected OSA If AHI <10: BP morning < BP evening
If AHI 10–≤50: BP morning = BP evening
If AHI >50: BP morning > BP evening
Sforza and 
Lugaresi48
253 suspected OSA In both simple snorers and OSA: BP morning > BP evening
SBP evening-to-morning rise correlated to AHI
Stradling et al59 448 subjects from general 
population
ODI4 and mean nocturnal respiratory effort independently correlated with evening-to-morning 
BP rise
Lavie-Nevo and 
Pillar61
2,009 suspected OSA SBP and DBP evening-to-morning rise correlated with AHI in men, but not in women
Ting et al63 263 simple snorers, UARS 
or OSA
Subjects with morning:evening BP ratio >11% (“morning surge” pattern) or with mean both 
morning and evening BP >130 mmHg (“constant high”) had higher AHI, lower lowest SaO2, 
longer T<90% and higher arousal index than subjects with morning:evening BP ratio <11% 
(“morning drop”) or both morning and evening mean BP <130 mmHg (“constant low”); similar 
percentage of sleep stages in all groups
Huang et al64 105 positional and 266 non-
positional OSA
Morning BP higher in nonpositional OSA; evening BP and evening-to-morning BP difference 
similar in positional and nonpositional OSA
Wang et al60 3246 OSA + 354 controls Progressive increase in morning/evening mean BP with increasing OSA severity
Mokros et al62 454 normotensive 
suspected OSA
AHI linearly correlated with evening-to-morning DBP rise, but not SBP rise
Note: Arousal index, number of arousals per hour; ODI4, number of oxyhemoglobin saturation falls ≥4% per hour.
Abbreviations: AHI, apnea/hypopnea index; BP, blood pressure; DBP, diastolic BP; ODI, oxygen desaturation index; OSA, obstructive sleep apnea; SaO2, oxyhemoglobin 
saturation; SBP, systolic BP; T<90%, time spent with oxyhemoglobin saturation <90%; UARS, upper airway resistance syndrome.
Table 2 24-Hour BP characteristics in obstructive sleep apnea: beyond dipping and nondipping
Authors Subjects under study Profiles
Noda et al76 21 OSA + 123 non-OSA Type 1: normal BP throughout the 24-hour period with nocturnal BP fall (OSA + non-OSA)
Type 2: progressive BP elevation from onset of sleep to early morning (hypertensive OSA)
Type 3: elevated BP at any time (hypertensive OSA)
Nagata et al77 5 non-OSA, 10 mild OSA, 
12 moderate OSA, 27 
severe OSA
Nocturnal BP: moderate and severe OSA > non OSA
Morning BP: severe OSA > non OSA
Nocturnal BP fall: severe OSA < non OSA
Diurnal and evening BP: OSA = non OSA
Sasaki et al78 103 OSA Sustained type: both diurnal and nocturnal hypertension; profile related to OSA severity and sleep 
disruption
Surge type: only morning hypertension; profile related to reduced SWS
Control type: neither diurnal nor nocturnal hypertension
Nocturnal hypertension only: not analyzed, few patients
Cho et al79 Hypertensives, 35 OSA + 
23 non-OSA
Sleep-trough morning SBP surge: OSA > non-OSA
Abbreviations: BP, blood pressure; OSA, obstructive sleep apnea; SBP, systolic BP; SWS, slow-wave sleep.
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while a sustained high BP profile was associated with both 
OSA severity and altered sleep architecture, the MBPS was 
associated only with altered sleep architecture.78 Morning 
BP was the object of another study that found that the sever-
ity of sleep-respiratory disorders in hypertensive subjects, 
though not directly affecting morning BP, was independently 
correlated with the MBPS.83
Two longitudinal studies evaluated the incidence of a 
nondipping BP pattern in relationship to OSA in a general 
population cohort (the Wisconsin Sleep Cohort). In the 
first, an independent relationship between AHI values and 
incidence of systolic nondipping was demonstrated.84 In the 
second, the risk of developing systolic and diastolic nondip-
ping was significantly correlated with AHI values in REM, 
but not in non-REM sleep.85
In summary, cross-sectional studies have shown that 
high-severity sleep-respiratory disorders and altered sleep 
architecture may be related to increased BP, especially at 
night, and to reduced nocturnal BP dipping, but data were 
inconsistent, possibly due to numerous confounding fac-
tors. Longitudinal studies, coming from only one cohort, 
support a role of sleep-respiratory disorders, especially if 
occurring during REM sleep, as determinants of nondip-
ping BP.
Other measurements of BP variability
Besides the BP pattern over 24 hours, the SD of the mea-
surements taken with ABPM has been commonly used as 
a parameter of variability.68,74,86–91 Other parameters have 
been coefficient of variation,89 average real variability 
(ie, average of absolute differences between consecutive 
measurements),89 time rate index (ie, rate of change of BP 
over time, defined as the first derivative values of BP by 
time).87 Heterogeneous studies designs were evident. Two 
studies compared subjects with and without OSA,87,88 two 
compared hypertensive subjects with and without OSA,89,90 
one compared subjects with mild–moderate and severe 
OSA,91 one evaluated patients with moderate–severe OSA 
before and after continuous positive airway pressure (CPAP) 
treatment,86 and one evaluated OSA subjects with normoten-
sion, established hypertension, or masked hypertension.74 
Therefore, results of these studies are hard to compare. 
Some relationship between OSA and BP variability was 
observed in most of them. However, depending on the 
study, an effect of OSA was variably apparent on systolic 
or diastolic BP or on 24-hour, diurnal, or nocturnal BP. 
We believe that ABPM may roughly catch BP variability 
in the nocturnal hours in OSA for the reasons explained, 
which could account for some disagreement among stud-
ies. Little information is available on mid- and long-term 
BP variability in OSA. No effect on morning-to-morning 
BP was reported during CPAP withdrawal for 2 weeks, 
which suggested that OSA does not significantly influence 
midterm BP variability.92
Twenty-four-hour BP profile and 
cardiovascular risk
The characteristics of BP variability in OSA likely contribute 
to cardiovascular risk and to a peculiar temporal pattern of 
occurrence of cardiovascular events. Little direct evidence 
is available of a relationship between BP profile and cardio-
vascular risk in OSA. Among OSA patients studied with 
repeated morning and evening BP measurements, those with 
an MBPS showed higher high-sensitivity C-reactive protein 
levels.61 Similarly, among OSA patients studied by ABPM, 
nondippers showed higher levels of IL2 and high-sensitivity 
C-reactive protein than dippers.93,94 Patients with both moder-
ate–severe OSA and reverse-dipping BP profile showed worse 
brain white matter lesions than subjects with one condition 
alone.95 In a retrospective study, it was observed that OSA 
patients who had shown a nondipping-BP profile had a higher 
incidence of stroke, coronary artery disease, and heart failure 
in a 43-month period.96
A support to the role of the BP profile is also given by 
indirect evidence. While in the general population major 
cardiovascular events and sudden death occur preferentially 
in the morning hours,6 in OSA their distribution in the 
24-hour period seems to be different. Among subjects who 
had been studied by polysomnography and died from sudden 
cardiac death, the fatal events had a peak during the night if 
OSA had been diagnosed, and a nocturnal nadir in non-OSA 
subjects.97 According to a recent larger investigation, sudden 
cardiac deaths were evenly distributed in the 24 hours in OSA 
patients, whereas non-OSA subjects died preferentially in the 
morning.98 Two studies pointed out that in OSA patients, the 
onset of acute coronary syndrome was more frequent in the 
nocturnal hours, differently from subjects without OSA.99,100 
In addition, a few studies showed that wakeup strokes were 
strongly associated with OSA.101,102 Multiple factors may 
be responsible for triggering cardiovascular events at night, 
but it is likely that the altered BP profile plays an important 
role. All these findings indicate that risk associated with 
OSA increases especially at night and not in the morning. 
Therefore, in OSA nocturnal hypertension and a nondipping 
or reverse-dipping pattern might influence cardiovascular 
risk more than MBPS.
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OSA treatment and BP variability
In the management of OSA, the main focus is usually on 
the elimination of respiratory disorders during sleep. Treat-
ment of OSA can reduce many symptoms and risk factors, 
usually to an extent that is proportional to the correction 
of the respiratory disorders.103 It would also be important 
to reduce cardiovascular risk factors, including abnormal 
BP during sleep. For a long time, treatment of hypertensive 
patients has been aimed almost exclusively at maintaining 
normal BP levels, not rarely measured just as office diurnal 
BP values, which are often misleading. More recently, BP 
variability, including the 24-hour profile of BP, has been 
brought to the attention of clinicians as a possible target of 
treatment. A chronotherapy of hypertension, aimed at more 
carefully controlling nocturnal BP levels and converting a 
nondipping into a dipping BP profile, has been proposed as 
a convenient treatment strategy.104
In OSA, antihypertensive drugs may reduce BP levels, but 
have at most a limited effect, if any, on sleep-respiratory dis-
orders, such that they cannot substantially reduce nocturnal 
BP variability. Instead, elimination of respiratory disorders 
during sleep may be expected to prevent BP peaks and to 
reduce variability in BP during the night. Meta-analyses have 
consistently shown that on average, OSA treatment reduces 
BP by a small amount, with somewhat larger reduction in noc-
turnal levels.105–108 Effects are more evident in patients with 
severe OSA and with high compliance with treatment.105,107 
CPAP treatment and pharmacological therapies have additive 
effects on BP,109,110 so the best strategy to treat hypertension 
and improve characteristics of BP variability in OSA usually 
includes both kinds of therapy.
A timely administration of antihypertensive drugs might 
reduce nocturnal BP and restore normal dipping, but few 
data are available on chronotherapy for altered BP in OSA. 
A crossover study demonstrated that when antihypertensive 
therapy was administered in the evening, nifedipine was 
more effective than carvedilol in decreasing mean and mini-
mum nocturnal systolic BP, but only carvedilol decreased 
sleep BP peak.111 A similar decrease in nocturnal BP peak 
was observed in a patient with evening administration of 
doxazosin.112 A crossover study demonstrated that evening 
administration of valsartan, associated or not with amlo-
dipine, was more effective than morning administration in 
reducing nocturnal BP and converting a nondipping into a 
dipping BP profile.113 Instead, no advantage was found with 
evening compared to morning administration of perindopril 
in a randomized controlled trial conducted on hypertensive 
OSA patients.110
Several studies, largely differing in design and objectives, 
have investigated effects of CPAP on BP variability (Table 3). 
One group of studies evaluated nocturnal BP by means of 
beat-by-beat measurements. They demonstrated that BP 
variability during sleep acutely decreased while CPAP was 
applied,39,46,114 which is a consequence of a reduction in the 
number of BP peaks.115 Furthermore, beat-by-beat BP vari-
ability before CPAP initiation was higher than immediately 
after CPAP withdrawal, following an approximately 5-month 
treatment period,116 in agreement with the observation of 
lower postapneic BP peaks at CPAP withdrawal.50 A second 
group of studies used ABPM and analyzed the change in 
24-hour BP variability.67,70,117–123 The period of observation 
ranged between 1 day and 3 months, depending on the 
study. In all cases, some of the patients who were nondip-
pers before CPAP initiation were found to be dippers after 
treatment, but the proportion of patients showing this change 
largely differed among studies. No effect of ≤1-week CPAP 
treatment on BP measurement SD during the day or night 
was reported.86 Finally, a group of investigations evaluated 
BP variability with office or home BP measurements, and 
found some effect of CPAP treatment on waking systolic 
BP variability.92,124 In summary, CPAP treatment acutely 
decreases nocturnal very short-term BP variability. A few 
weeks of CPAP treatment may convert a nondipping into a 
dipping 24-hour BP profile in some patients and cause some 
decrease in diurnal BP variability, but more data are neces-
sary to explore these aspects better. CPAP treatment may 
also decrease BP reactivity to sleep apneas,50 such that acute 
CPAP withdrawal does not immediately revert BP variability 
to the level observed before treatment initiation.
Conclusion
Current knowledge suggests that BP behavior in OSA plays 
a role in the increased cardiovascular risk that is typical of 
this disorder, not only through its high diurnal and even more 
its nocturnal BP values but also through the characteristics 
of its variability. In fact, high very short-term variability, 
nondipping BP profile and high MBPS, which are all com-
mon in OSA, are known risk factors.
Among the characteristics of BP variability in OSA, the 
most peculiar is the periodic recurrence of short BP peaks. 
However, this is not exclusive to OSA, as nocturnal BP 
peaks can be observed in other conditions with periodicity, in 
particular in patients with periodic leg movements.125 Some-
times, BP peaks reach very high levels. It is conceivable that 
a precise assessment of nocturnal BP that accurately takes 
into account values and duration of peaks carries prognostic 
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significance. In fact, it has been found that maximum BP 
values measured over several days may be better related to 
several cardiovascular outcomes than mean values.126 Today, a 
precise detection of hypertensive peaks is not easy in common 
clinical practice. Research of new monitoring systems is in 
progress. The new techniques appear promising,56,57 although 
they still need to be better validated and probably refined.
Once BP variability is evaluated, effective strategies 
should be applied to improve it. BP variability may be 
reduced with treatment of disordered breathing events or 
with a pharmacological treatment directly addressing BP. As 
described earlier, many studies have observed a reduction in 
BP variability and an improvement of BP profile with CPAP 
treatment, but not all findings have been in agreement. It is 
Table 3 Changes in BP variability associated with CPAP treatment
Methodology Authors Subjects, design BP variability changes
Beat-by-beat BP 
measurements
Ali et al39 8 OSA with and without CPAP In a 30-minute period during sleep, lower coefficient of variation 
of SBP and DBP with than without CPAP
Sforza et al46 25 OSA with and without CPAP During first night with CPAP, decreased coefficient of variation of 
SBP and DBP in all sleep stages
Bonsignore et al116 10 normotensive OSA before OSA 
treatment and after treatment 
withdrawal
In the first night of CPAP withdrawal after a 5.5±3.7-month 
treatment, lower SD of SBP and DBP during stage NREM2, but 
not during waking, than before CPAP initiation
Marrone et al50 13 OSA under no pharmacological 
therapy before OSA treatment and 
after treatment withdrawal
In apneic cycles during the first night of CPAP withdrawal after 
a 4.9±3.4-month treatment, smaller SBP and DBP surges than in 
apneic cycles occurring before CPAP initiation
Bonsignore et al114 18 OSA with and without CPAP In the first night with CPAP, decrease in SD of both SBP and DBP 
in stages NREM2 and REM, and decrease only in SD of DBP during 
nocturnal waking
Carter et al115 17 OSA with OHS with and without 
CPAP
During the first night (titration) and after 6 weeks with CPAP, 
similar reduction in the rate of nocturnal BP surges
ABPM 
measurements
Pankow et al67 34 OSA with and without CPAP After 2–4 nights with CPAP, 17 of 27 who were nondippers at 
baseline showed dipping
Engleman et al117 13 OSA with placebo and CPAP 
(crossover RCT)
After ≥3-week treatment, nonsignificant change in prevalence of 
nondipping BP pattern
Akashiba et al70 38 OSA without and with CPAP 15 of 22 nondippers at baseline showed dipping at the third day of 
CPAP therapy
Bao et al86 41 OSA with placebo or CPAP 
(parallel RCT)
In patients receiving CPAP for either 1 or for 7 nights and in 
patients receiving placebo, similar decrease in SD of SBP, DBP, and 
MBP both during the day and during the night
Dursunoğlu et al118 12 OSA with and without auto-
CPAP
The first day with autoadjusting CPAP, reduction in SD of SBP, 
DBP and MBP at night, but not during the day
Campos-Rodriguez 
et al119
68 hypertensive OSA with placebo 
or CPAP (parallel RCT)
After a 4-week treatment, proportion of patients turning BP 
pattern from nondipper to dipper not significantly different 
between placebo and CPAP
Wang et al120 60 mild OSA and 48 moderate–
severe OSA with hypertension with 
and without CPAP
After 3-month CPAP or surgery, 23 of 31 mild OSA and 19 of 
28 moderate–severe OSA patients turned from nondippers to 
dippers
Martínez-García 
et al121
194 OSA with resistant hypertension 
with and without CPAP (parallel 
RCT)
After 12 weeks, fewer patients treated by CPAP than controls 
showed nondipper or riser profiles
Muxfeldt et al122 117 moderate–severe OSA with 
resistant hypertension with placebo 
or CPAP (parallel RCT)
After 6 months, NS difference between CPAP and placebo 
treatment in prevalence of nondipping and riser BP patterns
Lemmer et al123 17 OSA with and without CPAP 5 of 14 nondippers at baseline showed dipping after 8 weeks with 
CPAP
Office or home 
BP measurements
Pengo et al124 78 OSA with and without auto-
CPAP
After a 3-week autoadjusting CPAP therapy, decrease in SD of 
three repeated waking SBP but not DBP measurements
Lettau et al92 175 OSA continuing or withdrawing 
CPAP (parallel RCT)
After a 2-week CPAP withdrawal, increased SD of three 
consecutive office morning SBP but not of DBP measurements; in 
the same period, no effect on day-to-day BP variability
Abbreviations: ABPM, ambulatory blood pressure monitoring; CPAP, continuous positive airway pressure; DBP, diastolic BP; MBP, mean BP; NREM, non-rapid eye 
movement; OSA, obstructive sleep apnea; RCT, randomized controlled trial; SBP, systolic BP.
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unknown whether differing interindividual effects of CPAP 
on BP variability contribute to the variable efficacy of CPAP. 
Knowledge on pharmacological treatment of hypertension 
to be preferentially used in OSA is still limited,127,128 and the 
few available data on chronotherapy for hypertension in OSA 
are inconsistent. Besides, more experience is required with 
regard to combined effects of treatment of OSA by CPAP, 
weight loss, or other treatments and antihypertensive phar-
macological therapy.
Today, although OSA is believed to increase cardiovascu-
lar risk, cardiovascular benefits of OSA treatment are ques-
tioned, based on the results of randomized controlled trials.129 
Research is on the way for a personalized approach to the 
treatment of several diseases, including OSA.130 Individual 
characteristics of BP variability could be one factor to take 
into consideration in the management of OSA patients and 
in the choice of a specific therapeutic approach to reduce the 
cardiovascular burden of the disease.
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